Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3138-3145

  Kraft, Michael S ^a   Henning, Golo ^a   Fickenscher, Helmut ^a   Lengenfelder, Doris ^a   Tschopp, Jürg ^b   Fleckenstein, Bernhard ^a   Meinl, Edgar ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE ACTIVATION; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS REPLICATION;

EID: 0031949943     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3138-3145.1998     Document Type: Article

References (53)

1. Allday, M. J., A. Sinclair, G. Parker, D. H. Crawford, and P. J. Farrell. 1995. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1382-1391.
2. Austin, P. J., E. Flemington, C. N. Yandava, J. L. Strominger, and S. H. Speck. 1988. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. USA 85:3678-3682.
3. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G. H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli, and J. I. Cohen. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-1176.
4. Biesinger, B., I. Müller Fleckenstein, B. Simmer, G. Lang, S. Wittmann, E. Platzer, R. C. Desrosiers, and B. Fleckenstein. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89:3116-3119.
5. Biesinger, B., A. Y. Tsygankov, H. Fickenscher, F. Emmrich, B. Fleckenstein, J. B. Bolen, and B. M. Bröker. 1995. The product of the herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells. J. Biol. Chem. 270:4729-4734.
6. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, A. Wilson, L. E. French, J. L. Browning, H. R. MacDonald, and J. Tschopp. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79-88.
7. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98.
8. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokos, D. L. Nelson, and J. E. Balow. 1991. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739-1747.
9. Brauweiler, A., J. E. Garrus, J. C. Reed, and J. K. Nyborg. 1997. Repression of Bax gene expression by the HTLV-I Tax protein, implications for suppression of apoptosis in virally infected cells. Virology 231:135-140.
10. Bröker, B. M., M. S. Kraft, U. Klauenberg, F. Le Deist, J.-P. de Villartay, B. Fleckenstein, B. Fleischer, and E. Meinl. 1997. Activation induces apoptosis in herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1). Eur. J. Immunol. 27:2774-2780.
11. Bröker, B. M., A. Y. Tsygankov. I. Müller Fleckenstein, A. H. Guse, N. A. Chitaev, B. Biesinger, B. Fleckenstein, and F. Emmrich. 1993. Immortalization of human T cell clones by herpesvirus saimiri. Signal transduction analysis reveals functional CD3, CD4, and IL-2 receptors. J. Immunol. 151: 1184-1192.
12. Chinnaiyan, A. M., C. G. Tepper, M. F. Seldin, K. O'Rourke, F. C. Kischkel, S. Hellbardt, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FADD/ MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
13. Cohen, J. J., R. C. Duke, V. A. Fadok, and K. S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267-293.
14. Copeland, K. F., A. G. Haaksma, J. Goudsmit, P. H. Krammer, and J. L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses 10:1259-1268.
15. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513-543.
16. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:7098-7108.
17. Fickenscher, H., B. Biesinger, A. Knappe, S. Wittmann, and B. Fleckenstein. 1996. Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J. Virol. 70:6012-6019.
18. Fickenscher, H., C. Bökel, A. Knappe, B. Biesinger, E. Meinl, B. Fleischer, B. Fleckenstein, and B. M. Bröker. 1997. Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus saimiri. J. Virol. 71:2252-2263.
19. Finke, J., R. Fritzen, P. Ternes, P. Trivedi, K. J. Bross, W. Lange, R. Mertelsmann, and G. Dolken. 1992. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 80:459-469.
20. Gattei, V., M. Degan, A. Gloghini, A. De Iuliis, S. Improta, F. M. Rossi, D. Aldinucci, V. Perin, D. Serraino, R. Babare, V. Zagonel, H. J. Gruss, A. Carbone, and A. Pinto. 1997. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 89:2048-2059.
21. Gregory, C. D., C. Dive, S. Henderson, C. A. Smith, G. T. Williams, J. Gordon, and A. B. Rickinson. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612-614.
22. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J. Cerottini, and J. Tschopp. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366.
23. Henderson, S., M. Rowe, C. Gregory, D. Croom Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
24. Herrmann, M., H. M. Lorenz, R. Voll, M. Grunke, W. Woith, and J. R. Kalden. 1994. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids. Res. 22:5506-5507.
25. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
26. Hollsberg, P., K. W. Wucherpfennig, L. J. Ausubel, V. Calvo, B. E. Bierer, and D. A. Hafler. 1992. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. J. Immunol. 148:3256-3263.
27. Hu, S., C. Vincenz, M. Buller, and V. M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor-1-induced apoptosis. J. Biol. Chem. 9621-9624.
28. Jung, J. L., S. M. Lang, U. Friedrich, T. Jun, T. M. Roberts, R. C. Desrosiers, and B. Biesinger. 1995. Identification of Lck-binding elements in tip of herpesvirus saimiri. J. Biol. Chem. 270:20660-20667.
29. Kitson, J., T. Raven, Y. P. Jiang, D. V. Goeddel, K. M. Giles, K. T. Pun, C. J. Grinham, R. Brown, and S. N. Farrow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384:372-375.
30. Knappe, A., C. Hiller, M. Thurau, S. Wittmann, H. Hofmann, B. Fleckenstein, and H. Fickenscher. 1997. The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J. Virol. 71:9124-9133.
31. Lee, S. Y., C. G. Park, and Y. Choi. 1996. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:669-674.
32. Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739-742.
33. Marchini, A., B. Tomkinson, J. I. Cohen, and E. Kieff. 1991 BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 65:5991-6000.
34. Marsters, S. A., J. P. Sheridan, C. J. Donahue, R. M. Pitti, C. L. Gray, A. D. Goddard, K. D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol. 6:1669-1676.
35. Martin, J. M., D. Veis, S. J. Korsmeyer, and B. Sugden. 1993. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol. 67:5269-5278.
36. Meinl, E., B. A. 't Hart, R. E. Bontrop, R. M. Hoch, A. Iglesias, R. de Waal Malefyt, H. Fickenscher, I. Müller Fleckenstein, B. Fleckenstein, H. Wekerle, R. Hohlfeld, and M. Jonker. 1995. Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkeys. Int. Immunol. 7:1489-1495.
37. Meinl, E., H. Fickenscher, R. M. Hoch, R. de Waal Malefyt, B. A. 't Hart, H. Wekerle, R. Hohlfeld, and B. Fleckenstein. 1997. Growth transformation of antigen-specific T cell lines from rhesus monkeys by herpesvirus saimiri. Virology 229:175-182.
38. Meinl, E., R. Hohlfeld, H. Wekerle, and B. Fleckenstein. 1995. Immortalization of human T cells by herpesvirus saimiri. Immunol. Today 16:55-58.
39. Mittrücker, H. W., I. Müller Fleckenstein, B. Fleckenstein, and B. Fleischer. 1992. CD2-mediated autocrine growth of herpes virus saimiri-transformed human T lymphocytes. J. Exp. Med. 176:909-913.
40. Nava, V. E., E. H.-Y. Cheng, M. Veliuona, S. Zou, R. J. Clem, M. L. Mayer, and J. M. Hardwick. 1997. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:4118-4122.
41. Pan, G., J. Ni, Y.-F. Wei, G.-L. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818.
42. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276:111-113.
43. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27:1207-1212.
44. Schneider, P., J. L. Bodmer, M. Thome, K. Hofmann, N. Holler, and J. Tschopp. 1997. Characterization of two receptors for TRAIL. FEBS Lett. 416:329-334.
45. Screaton, G. R., X.-N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94:4615-4619.
46. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, A. D. Goddard, P. Godowski, and A. Ashkenazi. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821.
47. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519-560.
48. Sinclair, A. J., M. G. Jacquemin, L. Brooks, F. Shanahan, M. Brimmell, M. Rowe, and P. J. Farrell. 1994. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Virology 199:339-353.
49. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. H. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317-322.
50. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.-L. Bodmer, M. Schröter, C. Scaffidi, P. H. Krammer, M. E. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
51. Vercammen, C., and J. L. Ceuppens. 1987. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process. Cell. Immunol. 104:24-36.
52. Weber, F., E. Meinl, K. Drexler, A. Czlonkowska, S. Huber, H. Fickenscher, I. Müller Fleckenstein, B. Fleckenstein, H. Wekerle, and R. Hohlfeld. 1993. Transformation of human T-cell clones by herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells. Proc. Natl. Acad. Sci. USA 90:11049-11053.
53. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351.